Members – observers

Associate, Pureos Bioventures  At Pureos, Ximing is active in deal flow generation, investment due diligence, investment and exit transactions as well as fundraising support. In addition to Tridek-One, Ximing is currently BoD observer at Araris Biotech and Engimmune Therapeutics. He obtained his PhD at the European Molecular Biology Laboratory and

Associate, Bioqube Ventures,   Alex joined Bioqube in 2016 as a member of the investment team. He is involved in the entire investment process for both portfolio investments and early stage venture creation as part of Bioqube’s dual investment model, from sourcing deals to advancing investment opportunities and performing due diligence.